Erik Halvorsen

Erik Halvorsen is a seasoned professional in the healthcare investment banking and strategic advisory sectors, currently serving as a Partner at pH Partners and pH Blueprint. In these roles, Erik focuses on capital raises, M&A, partnerships, and strategic advisory services for clients in therapeutics, devices, diagnostics, and digital health technology. As a Member of the Board of Directors at FAR Biotech, Erik contributes to the advancement of in silico drug discovery aimed at addressing various diseases. Previously, Erik held key positions including Chief Business & Strategy Officer for Forbes Technology Council, Director of the Innovation Institute and TMCx Accelerator at Texas Medical Center, and Senior Director of Technology Transfer & Industry Collaborations at Tufts University. Erik's educational background includes a Ph.D. in Neuropharmacology from the University of Virginia.